There is a subclinical activation of coagulation and fibrinolysis system in lung cancer.
Alterations in hemostatic system are seen frequently in lung cancer correlated with the …

Activation of coagulation and fibrinolysis is frequently encountered among cancer patients.
Such tumors are supposed to be associated with higher risk of invasion, metastases and …

Both experimental and clinical data have shown that coagulation disorders are common in
patients with cancer although clinical symptoms occur rarely. A prethrombotic state is …

AIMS: An elevated plasma d-dimer level indicates the activation of coagulation and
fibrinolysis. In the present study, we investigated the association of pre-treatment …

Previous studies have shown that activation of coagulation has an impact on the clinical
course of lung cancer. This study was carried out to assess the potential prognostic …

Abstract Background and Aim Activation of coagulation and fibrinolysis is frequently
encountered among cancer patients. Such tumors are supposed to be associated with …

Purpose The plasma D-dimer (D-dimer) level, a marker of hypercoagulation, has been
reported to be associated with survival in several types of cancers. This retrospective study …

Aims and Backgrounds Plasma concentrations of several proteases of the coagulation
system have been shown to predict prognosis in malignancy. The study was aimed to …

Patients with cancer may present with one or more circulatory markers of haemostatic
activation which may be associated with tumor growth and cancer cell dissemination. In our …

An elevated plasma D-dimer level indicates the activation of coagulation and fibrinolysis.
Several studies suggested that high level of plasma D-dimer was associated with the …